U.S. markets open in 32 minutes

Landec Corporation (LNDC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.210.00 (0.00%)
At close: 4:00PM EST

10.24 +0.03 (0.29%)
Before hours: 8:50AM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close10.21
Open10.21
Bid7.47 x 800
Ask0.00 x 800
Day's Range10.10 - 10.27
52 Week Range7.48 - 12.09
Volume78,517
Avg. Volume142,963
Market Cap298.56M
Beta (5Y Monthly)1.07
PE Ratio (TTM)N/A
EPS (TTM)-1.53
Earnings DateDec 31, 2020 - Jan 04, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Reflecting on Landec's (NASDAQ:LNDC) Share Price Returns Over The Last Three Years
    Simply Wall St.

    Reflecting on Landec's (NASDAQ:LNDC) Share Price Returns Over The Last Three Years

    In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

  • Barrons.com

    The Bull Case for Bank of America

    The company ultimately will be able to reach 90% of the U.S. population, an analyst says, and might resume buybacks and dividend growth in 2021. Also, Wall Street views on Domino’s Pizza, Landec, Walmart, and Paycom Software.

  • Landec Corp (LNDC) Q1 2021 Earnings Call Transcript
    Motley Fool

    Landec Corp (LNDC) Q1 2021 Earnings Call Transcript

    With me on the call today is Dr. Albert Bolles, Landec's Chief Executive Officer; Brian McLaughlin, Landec's Chief Financial Officer; and Jim Hall, President of Lifecore. As a leading innovator in diversified health and wellness solutions, Landec is comprised of two operating businesses, Lifecore Biomedical and Curation Foods. Lifecore Biomedical is a fully integrated contract development and manufacturing organization, or CDMO that offers highly differentiated capabilities in the development, fill and finish of difficult to manufacture pharmaceutical products distributed in syringes and vials.